Literature DB >> 30093290

Revisiting assumptions about age-based mixing representations in mathematical models of sexually transmitted infections.

C W Easterly1, F Alarid-Escudero2, E A Enns3, S Kulasingam4.   

Abstract

BACKGROUND: Sexual mixing between heterogeneous population subgroups is an integral component of mathematical models of sexually transmitted infections (STIs). This study compares the fit of different mixing representations to survey data and the impact of different mixing assumptions on the predicted benefits of hypothetical human papillomavirus (HPV) vaccine strategies.
METHODS: We compared novel empirical (data-driven) age mixing structures with the more commonly-used assortative-proportionate (A-P) mixing structure. The A-P mixing structure assumes that a proportion of sexual contacts - known as the assortativity constant, typically estimated from survey data or calibrated - occur exclusively within one's own age group and the remainder mixes proportionately among all age groups. The empirical age mixing structure was estimated from the National Survey on Sexual Attitudes and Lifestyles 3 (Natsal-3) using regression methods, and the assortativity constant was estimated from Natsal-3 as well. Using a simplified HPV transmission model under each mixing assumption, we calibrated the model to British HPV16 prevalence data, then estimated the reduction in steady-state prevalence and the number of infections averted due to expanding HPV vaccination from 12- through 26-year-old females alone to 12-year-old males or 27- to 39-year-old females.
RESULTS: Empirical mixing provided a better fit to the Natsal-3 data than the best-fitting A-P structure. Using the model with empirical mixing as a reference, the model using the A-P structure often under- or over-estimated the benefits of vaccination, in one case overestimating by 2-fold the number of infections prevented due to extended female catch-up in a high vaccine uptake setting.
CONCLUSIONS: An empirical mixing structure more accurately represents sexual mixing survey data, and using the less accurate, yet commonly-used A-P structure has a notable effect on estimates of HPV vaccination benefits. This underscores the need for mixing structures that are less dependent on unverified assumptions and are directly informed by sexual behavior data.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Human papillomavirus; Mathematical modelling; Sexual behavior; Sexual mixing; Sexually transmitted infections

Mesh:

Substances:

Year:  2018        PMID: 30093290      PMCID: PMC6367925          DOI: 10.1016/j.vaccine.2018.07.058

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  27 in total

1.  The cost-effectiveness of male HPV vaccination in the United States.

Authors:  Harrell W Chesson; Donatus U Ekwueme; Mona Saraiya; Eileen F Dunne; Lauri E Markowitz
Journal:  Vaccine       Date:  2011-08-02       Impact factor: 3.641

2.  Bayesian Methods for Calibrating Health Policy Models: A Tutorial.

Authors:  Nicolas A Menzies; Djøra I Soeteman; Ankur Pandya; Jane J Kim
Journal:  Pharmacoeconomics       Date:  2017-06       Impact factor: 4.981

3.  Modeling the impact of screening policy and screening compliance on incidence and mortality of cervical cancer in the post-HPV vaccination era.

Authors:  Birgitte Freiesleben de Blasio; Aileen Rae Neilson; Marianne Klemp; Finn Egil Skjeldestad
Journal:  J Public Health (Oxf)       Date:  2012-06-15       Impact factor: 2.341

4.  Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity.

Authors:  Marc Brisson; Nicolas van de Velde; Eduardo L Franco; Mélanie Drolet; Marie-Claude Boily
Journal:  J Infect Dis       Date:  2011-08-01       Impact factor: 5.226

5.  Estimating and Projecting Trends in HIV/AIDS Generalized Epidemics Using Incremental Mixture Importance Sampling.

Authors:  Adrian E Raftery; Le Bao
Journal:  Biometrics       Date:  2010-12       Impact factor: 2.571

6.  Nonidentifiability in Model Calibration and Implications for Medical Decision Making.

Authors:  Fernando Alarid-Escudero; Richard F MacLehose; Yadira Peralta; Karen M Kuntz; Eva A Enns
Journal:  Med Decis Making       Date:  2018-10       Impact factor: 2.583

7.  Type-specific human papillomavirus biological features: validated model-based estimates.

Authors:  Iacopo Baussano; K Miriam Elfström; Fulvio Lazzarato; Anna Gillio-Tos; Laura De Marco; Francesca Carozzi; Annarosa Del Mistro; Joakim Dillner; Silvia Franceschi; Guglielmo Ronco
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

8.  The impact of HPV female immunization in Italy: model based predictions.

Authors:  Giorgio Guzzetta; Luca Faustini; Donatella Panatto; Roberto Gasparini; Piero Manfredi
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

9.  The potential impact of vaccination on the prevalence of gonorrhea.

Authors:  David P Wilson; Kate L Seib; Andrew P Craig; Richard T Gray; Jennifer L Edwards; Michael A Apicella; Michael P Jennings
Journal:  Vaccine       Date:  2015-07-17       Impact factor: 3.641

10.  Model for assessing human papillomavirus vaccination strategies.

Authors:  Elamin H Elbasha; Erik J Dasbach; Ralph P Insinga
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.